Fennec Pharmaceuticals Inc.
Organization details
- Legal name
- Fennec Pharmaceuticals Inc.
- Former names
- Adherex Technologies Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- British Columbia, Canada
- Headquarters city
- Research Triangle Park
- Headquarters state / province
- North Carolina
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- FENC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001211583
Board of directors
-
Adrian Haigh · DirectorSince 2023
-
Chris A. Rallis · DirectorSince 2023
-
Jeffrey S. Hackman · Director · Chief Executive OfficerSince 2024
-
Jodi A. Cook · DirectorSince 2023
-
Khalid Islam · DirectorSince 2023
-
Marco Maria Brughera · DirectorSince 2023
-
Rosty Raykov · Director · CHIEF EXECUTIVE OFFICERSince 2023
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
44.9% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.8%
-
99.1%
-
99.3%
-
99.4%
-
99.6%
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Gain Therapeutics Inc. Same sectorvia Khalid Islam
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $11,822,154
- 18 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 31, 2026 | Andrade Robert Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +1,703 | — | — |
| Oct 31, 2026 | Cioffi Christiana Marie Officer (Chief Strategy Officer) | Grant or award | +156 | — | — |
| Oct 31, 2026 | Evans Terry L Officer (Chief Commercial Officer) | Grant or award | +168 | — | — |
| Oct 31, 2026 | Jeffrey S. Hackman Director, Officer (Chief Executive Officer) | Grant or award | +1,159 | — | — |
| Oct 31, 2026 | Sayad Pierre Sargis Officer (Chief Medical Officer) | Grant or award | +168 | — | — |
| Oct 12, 2026 | Andrade Robert Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +3,846 | $5.53 | $21,268 |
| Oct 12, 2026 | Cioffi Christiana Marie Officer (Chief Strategy Officer) | Grant or award | +3,946 | $5.53 | $21,821 |
| Oct 12, 2026 | Evans Terry L Officer (Chief Commercial Officer) | Grant or award | +2,326 | $5.53 | $12,863 |
| Oct 12, 2026 | Jeffrey S. Hackman Director, Officer (Chief Executive Officer) | Grant or award | +2,224 | $5.53 | $12,299 |
| Oct 12, 2026 | Sayad Pierre Sargis Officer (Chief Medical Officer) | Grant or award | +3,846 | $5.53 | $21,268 |
| Sep 30, 2026 | Andrade Robert Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +1,703 | — | — |
| Sep 30, 2026 | Cioffi Christiana Marie Officer (Chief Strategy Officer) | Grant or award | +156 | — | — |
| Sep 30, 2026 | Evans Terry L Officer (Chief Commercial Officer) | Grant or award | +168 | — | — |
| Sep 30, 2026 | Jeffrey S. Hackman Director, Officer (Chief Executive Officer) | Grant or award | +1,159 | — | — |
| Sep 30, 2026 | Sayad Pierre Sargis Officer (Chief Medical Officer) | Grant or award | +168 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Fennec Pharmaceuticals Inc.
Who is the CEO of Fennec Pharmaceuticals Inc.?
Jeffrey S. Hackman has been Fennec Pharmaceuticals Inc.'s Chief Executive Officer since August 2024.
How many directors are on Fennec Pharmaceuticals Inc.'s board?
Fennec Pharmaceuticals Inc.'s board has 7 directors: Adrian Haigh, Chris A. Rallis, Jeffrey S. Hackman, Jodi A. Cook, Khalid Islam, Marco Maria Brughera and Rosty Raykov.
Are Fennec Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Fennec Pharmaceuticals Inc. insiders made no open-market purchases and sold $11.8 million of shares in 18 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="fennec-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.